Technology Transfer: door opener for collaboration opportunities
With targeted technology transfer, PSI pursues the goal of strengthening the competitiveness and innovative strength of Swiss companies in particular through an active exchange between research and industry. New knowledge and findings from research should lead to new ideas, problem solutions and marketable innovations.
The technology transfer team at PSI represents the interface between research and third parties and is a door opener for collaborations with industry, SMEs or academic partners.
Latest News
InterAx Biotech revolutionises drug development with new modes of action
InterAx Biotech AG, a spin-off company of the Paul Scherrer Institute and ETH, is setting new standards in drug development with its advanced AI platform. By uncovering novel cellular signalling pathways, the company is paving the way for innovative therapies in the fields of diabetes, obesity and immuno-oncology.